Wakamoto Pharmaceutical Co., Ltd. had a revenue of 1.97B in the quarter ending Dec 31, 2023, with 11.94%. This bring the company's revenue in the last twelve months to 7.98B, Increased -3.39%. In the fiscal year ending Mar 31, 2024, Wakamoto Pharmaceutical Co., Ltd. had annual revenue of 7.74B with -10.65% growth.